0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Fibrinogen Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8161
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Human Fibrinogen Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Fibrinogen Market Research Report 2025

Code: QYRE-Auto-8161
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Fibrinogen Market Size

The global market for Human Fibrinogen was valued at US$ 1059 million in the year 2024 and is projected to reach a revised size of US$ 2866 million by 2031, growing at a CAGR of 15.5% during the forecast period.

Human Fibrinogen Market

Human Fibrinogen Market

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Fibrinogen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Fibrinogen.
The Human Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Fibrinogen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Fibrinogen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Fibrinogen Market Report

Report Metric Details
Report Name Human Fibrinogen Market
Accounted market size in year US$ 1059 million
Forecasted market size in 2031 US$ 2866 million
CAGR 15.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Octapharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Fibrinogen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Fibrinogen Market growing?

Ans: The Human Fibrinogen Market witnessing a CAGR of 15.5% during the forecast period 2025-2031.

What is the Human Fibrinogen Market size in 2031?

Ans: The Human Fibrinogen Market size in 2031 will be US$ 2866 million.

What is the market share of major companies in Human Fibrinogen Market?

Ans: Global top five manufacturers hold a share about 90%.

What is the Human Fibrinogen Market share by type?

Ans: In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%.

Who are the main players in the Human Fibrinogen Market report?

Ans: The main players in the Human Fibrinogen Market are CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Octapharma

What are the Application segmentation covered in the Human Fibrinogen Market report?

Ans: The Applications covered in the Human Fibrinogen Market report are Congenital Fibrinogen Deficiency, Surgical Procedures

What are the Type segmentation covered in the Human Fibrinogen Market report?

Ans: The Types covered in the Human Fibrinogen Market report are Human Fibrinogen Concentrate, Animal Fibrinogen Concentrate

Recommended Reports

Fibrinogen and Derivatives

Coagulation & Hemostasis

Blood Products & Therapies

1 Human Fibrinogen Market Overview
1.1 Product Definition
1.2 Human Fibrinogen by Type
1.2.1 Global Human Fibrinogen Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Fibrinogen Concentrate
1.2.3 Animal Fibrinogen Concentrate
1.3 Human Fibrinogen by Application
1.3.1 Global Human Fibrinogen Market Value by Application (2024 VS 2031)
1.3.2 Congenital Fibrinogen Deficiency
1.3.3 Surgical Procedures
1.4 Global Human Fibrinogen Market Size Estimates and Forecasts
1.4.1 Global Human Fibrinogen Revenue 2020-2031
1.4.2 Global Human Fibrinogen Sales 2020-2031
1.4.3 Global Human Fibrinogen Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Fibrinogen Market Competition by Manufacturers
2.1 Global Human Fibrinogen Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Fibrinogen Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Fibrinogen Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Fibrinogen, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Fibrinogen, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Fibrinogen, Product Type & Application
2.7 Global Key Manufacturers of Human Fibrinogen, Date of Enter into This Industry
2.8 Global Human Fibrinogen Market Competitive Situation and Trends
2.8.1 Global Human Fibrinogen Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Fibrinogen Players Market Share by Revenue
2.8.3 Global Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Fibrinogen Market Scenario by Region
3.1 Global Human Fibrinogen Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Fibrinogen Sales by Region: 2020-2031
3.2.1 Global Human Fibrinogen Sales by Region: 2020-2025
3.2.2 Global Human Fibrinogen Sales by Region: 2026-2031
3.3 Global Human Fibrinogen Revenue by Region: 2020-2031
3.3.1 Global Human Fibrinogen Revenue by Region: 2020-2025
3.3.2 Global Human Fibrinogen Revenue by Region: 2026-2031
3.4 North America Human Fibrinogen Market Facts & Figures by Country
3.4.1 North America Human Fibrinogen Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Fibrinogen Sales by Country (2020-2031)
3.4.3 North America Human Fibrinogen Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Fibrinogen Market Facts & Figures by Country
3.5.1 Europe Human Fibrinogen Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Fibrinogen Sales by Country (2020-2031)
3.5.3 Europe Human Fibrinogen Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Fibrinogen Market Facts & Figures by Region
3.6.1 Asia Pacific Human Fibrinogen Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Fibrinogen Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Fibrinogen Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Fibrinogen Market Facts & Figures by Country
3.7.1 Latin America Human Fibrinogen Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Fibrinogen Sales by Country (2020-2031)
3.7.3 Latin America Human Fibrinogen Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Fibrinogen Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Fibrinogen Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Fibrinogen Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Fibrinogen Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Fibrinogen Sales by Type (2020-2031)
4.1.1 Global Human Fibrinogen Sales by Type (2020-2025)
4.1.2 Global Human Fibrinogen Sales by Type (2026-2031)
4.1.3 Global Human Fibrinogen Sales Market Share by Type (2020-2031)
4.2 Global Human Fibrinogen Revenue by Type (2020-2031)
4.2.1 Global Human Fibrinogen Revenue by Type (2020-2025)
4.2.2 Global Human Fibrinogen Revenue by Type (2026-2031)
4.2.3 Global Human Fibrinogen Revenue Market Share by Type (2020-2031)
4.3 Global Human Fibrinogen Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Fibrinogen Sales by Application (2020-2031)
5.1.1 Global Human Fibrinogen Sales by Application (2020-2025)
5.1.2 Global Human Fibrinogen Sales by Application (2026-2031)
5.1.3 Global Human Fibrinogen Sales Market Share by Application (2020-2031)
5.2 Global Human Fibrinogen Revenue by Application (2020-2031)
5.2.1 Global Human Fibrinogen Revenue by Application (2020-2025)
5.2.2 Global Human Fibrinogen Revenue by Application (2026-2031)
5.2.3 Global Human Fibrinogen Revenue Market Share by Application (2020-2031)
5.3 Global Human Fibrinogen Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Human Fibrinogen Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 LFB Group
6.2.1 LFB Group Company Information
6.2.2 LFB Group Description and Business Overview
6.2.3 LFB Group Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LFB Group Human Fibrinogen Product Portfolio
6.2.5 LFB Group Recent Developments/Updates
6.3 Shanghai RAAS Blood Products
6.3.1 Shanghai RAAS Blood Products Company Information
6.3.2 Shanghai RAAS Blood Products Description and Business Overview
6.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Portfolio
6.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.4 Jiangxi Boya Bio-Pharmaceutical
6.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
6.4.2 Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
6.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Portfolio
6.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
6.5 Hualan Biological Engineering
6.5.1 Hualan Biological Engineering Company Information
6.5.2 Hualan Biological Engineering Description and Business Overview
6.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hualan Biological Engineering Human Fibrinogen Product Portfolio
6.5.5 Hualan Biological Engineering Recent Developments/Updates
6.6 Harbin Pacific Biopharmaceutical
6.6.1 Harbin Pacific Biopharmaceutical Company Information
6.6.2 Harbin Pacific Biopharmaceutical Description and Business Overview
6.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Portfolio
6.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
6.7 GREEN CROSS
6.7.1 GREEN CROSS Company Information
6.7.2 GREEN CROSS Description and Business Overview
6.7.3 GREEN CROSS Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GREEN CROSS Human Fibrinogen Product Portfolio
6.7.5 GREEN CROSS Recent Developments/Updates
6.8 Shanghai XinXing Medical
6.8.1 Shanghai XinXing Medical Company Information
6.8.2 Shanghai XinXing Medical Description and Business Overview
6.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai XinXing Medical Human Fibrinogen Product Portfolio
6.8.5 Shanghai XinXing Medical Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Company Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Human Fibrinogen Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Octapharma Human Fibrinogen Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Fibrinogen Industry Chain Analysis
7.2 Human Fibrinogen Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Fibrinogen Production Mode & Process Analysis
7.4 Human Fibrinogen Sales and Marketing
7.4.1 Human Fibrinogen Sales Channels
7.4.2 Human Fibrinogen Distributors
7.5 Human Fibrinogen Customer Analysis
8 Human Fibrinogen Market Dynamics
8.1 Human Fibrinogen Industry Trends
8.2 Human Fibrinogen Market Drivers
8.3 Human Fibrinogen Market Challenges
8.4 Human Fibrinogen Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Fibrinogen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Fibrinogen Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Fibrinogen Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Fibrinogen Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global Human Fibrinogen Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Fibrinogen Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Fibrinogen Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Fibrinogen Average Price (USD/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Fibrinogen, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Fibrinogen, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Fibrinogen, Product Type & Application
 Table 12. Global Key Manufacturers of Human Fibrinogen, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Fibrinogen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Fibrinogen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Fibrinogen Sales by Region (2020-2025) & (Kg)
 Table 18. Global Human Fibrinogen Sales Market Share by Region (2020-2025)
 Table 19. Global Human Fibrinogen Sales by Region (2026-2031) & (Kg)
 Table 20. Global Human Fibrinogen Sales Market Share by Region (2026-2031)
 Table 21. Global Human Fibrinogen Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Fibrinogen Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Fibrinogen Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Fibrinogen Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Fibrinogen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 27. North America Human Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 28. North America Human Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Fibrinogen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 32. Europe Human Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 33. Europe Human Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Fibrinogen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Fibrinogen Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific Human Fibrinogen Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific Human Fibrinogen Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Fibrinogen Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Fibrinogen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America Human Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America Human Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Fibrinogen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Fibrinogen Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa Human Fibrinogen Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa Human Fibrinogen Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Fibrinogen Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Fibrinogen Sales (Kg) by Type (2020-2025)
 Table 51. Global Human Fibrinogen Sales (Kg) by Type (2026-2031)
 Table 52. Global Human Fibrinogen Sales Market Share by Type (2020-2025)
 Table 53. Global Human Fibrinogen Sales Market Share by Type (2026-2031)
 Table 54. Global Human Fibrinogen Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Fibrinogen Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Fibrinogen Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Fibrinogen Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Fibrinogen Price (USD/Kg) by Type (2020-2025)
 Table 59. Global Human Fibrinogen Price (USD/Kg) by Type (2026-2031)
 Table 60. Global Human Fibrinogen Sales (Kg) by Application (2020-2025)
 Table 61. Global Human Fibrinogen Sales (Kg) by Application (2026-2031)
 Table 62. Global Human Fibrinogen Sales Market Share by Application (2020-2025)
 Table 63. Global Human Fibrinogen Sales Market Share by Application (2026-2031)
 Table 64. Global Human Fibrinogen Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Fibrinogen Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Fibrinogen Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Fibrinogen Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Fibrinogen Price (USD/Kg) by Application (2020-2025)
 Table 69. Global Human Fibrinogen Price (USD/Kg) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 73. CSL Behring Human Fibrinogen Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. LFB Group Company Information
 Table 76. LFB Group Description and Business Overview
 Table 77. LFB Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 78. LFB Group Human Fibrinogen Product
 Table 79. LFB Group Recent Developments/Updates
 Table 80. Shanghai RAAS Blood Products Company Information
 Table 81. Shanghai RAAS Blood Products Description and Business Overview
 Table 82. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 83. Shanghai RAAS Blood Products Human Fibrinogen Product
 Table 84. Shanghai RAAS Blood Products Recent Developments/Updates
 Table 85. Jiangxi Boya Bio-Pharmaceutical Company Information
 Table 86. Jiangxi Boya Bio-Pharmaceutical Description and Business Overview
 Table 87. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product
 Table 89. Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
 Table 90. Hualan Biological Engineering Company Information
 Table 91. Hualan Biological Engineering Description and Business Overview
 Table 92. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 93. Hualan Biological Engineering Human Fibrinogen Product
 Table 94. Hualan Biological Engineering Recent Developments/Updates
 Table 95. Harbin Pacific Biopharmaceutical Company Information
 Table 96. Harbin Pacific Biopharmaceutical Description and Business Overview
 Table 97. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 98. Harbin Pacific Biopharmaceutical Human Fibrinogen Product
 Table 99. Harbin Pacific Biopharmaceutical Recent Developments/Updates
 Table 100. GREEN CROSS Company Information
 Table 101. GREEN CROSS Description and Business Overview
 Table 102. GREEN CROSS Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 103. GREEN CROSS Human Fibrinogen Product
 Table 104. GREEN CROSS Recent Developments/Updates
 Table 105. Shanghai XinXing Medical Company Information
 Table 106. Shanghai XinXing Medical Description and Business Overview
 Table 107. Shanghai XinXing Medical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 108. Shanghai XinXing Medical Human Fibrinogen Product
 Table 109. Shanghai XinXing Medical Recent Developments/Updates
 Table 110. Octapharma Company Information
 Table 111. Octapharma Description and Business Overview
 Table 112. Octapharma Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 113. Octapharma Human Fibrinogen Product
 Table 114. Octapharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Human Fibrinogen Distributors List
 Table 118. Human Fibrinogen Customers List
 Table 119. Human Fibrinogen Market Trends
 Table 120. Human Fibrinogen Market Drivers
 Table 121. Human Fibrinogen Market Challenges
 Table 122. Human Fibrinogen Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Fibrinogen
 Figure 2. Global Human Fibrinogen Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Fibrinogen Market Share by Type: 2024 & 2031
 Figure 4. Human Fibrinogen Concentrate Product Picture
 Figure 5. Animal Fibrinogen Concentrate Product Picture
 Figure 6. Global Human Fibrinogen Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Fibrinogen Market Share by Application: 2024 & 2031
 Figure 8. Congenital Fibrinogen Deficiency
 Figure 9. Surgical Procedures
 Figure 10. Global Human Fibrinogen Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Fibrinogen Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Human Fibrinogen Sales (2020-2031) & (Kg)
 Figure 13. Global Human Fibrinogen Average Price (USD/Kg) & (2020-2031)
 Figure 14. Human Fibrinogen Report Years Considered
 Figure 15. Human Fibrinogen Sales Share by Manufacturers in 2024
 Figure 16. Global Human Fibrinogen Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Human Fibrinogen Players: Market Share by Revenue in Human Fibrinogen in 2024
 Figure 18. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Human Fibrinogen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Human Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 21. North America Human Fibrinogen Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Human Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 25. Europe Human Fibrinogen Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Human Fibrinogen Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Human Fibrinogen Revenue Market Share by Region (2020-2031)
 Figure 33. China Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Human Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Human Fibrinogen Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Human Fibrinogen Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Human Fibrinogen Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Human Fibrinogen Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Human Fibrinogen by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Human Fibrinogen by Type (2020-2031)
 Figure 55. Global Human Fibrinogen Price (USD/Kg) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Human Fibrinogen by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Human Fibrinogen by Application (2020-2031)
 Figure 58. Global Human Fibrinogen Price (USD/Kg) by Application (2020-2031)
 Figure 59. Human Fibrinogen Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS